Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HaCaT Keratinocytes: A Differentiation-Competent Platform for Episomal Replication of HPV Type 11.

Viruses·2026
Same author

A Sequential Triple-Drug Strategy for Selective Targeting of p53-Mutant Cancers.

bioRxiv : the preprint server for biology·2025
Same author

Associations of Cruciferous Vegetable Intake with Breast Cancer Survival in a Diverse Population in the Pathways Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

DNA damage-induced phosphorylation of a replicative DNA helicase results in inhibition of DNA replication through attenuation of helicase function.

Nucleic acids research·2024
Same author

Proteomics Analysis of the Polyomavirus DNA Replication Initiation Complex Reveals Novel Functional Phosphorylated Residues and Associated Proteins.

International journal of molecular sciences·2024
Same author

Modifying Effects of Genetic Variations on the Association Between Dietary Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the Be-Well Study.

Molecular nutrition & food research·2024
Same journal

Clinical validation of tissue and liquid companion diagnostics for BRAF V600E detection in non-small cell lung cancers from the PHAROS study.

Cancer research communications·2026
Same journal

Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell Tumors.

Cancer research communications·2026
Same journal

Tissue context shapes distinct premalignant outcomes in a HPV16 E6/E7-mutant Pik3ca transgenic mouse model.

Cancer research communications·2026
Same journal

Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study.

Cancer research communications·2026
Same journal

A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer.

Cancer research communications·2026
Same journal

DNA Methyltransferase Inhibition Prevents Platinum-Induced Ovarian Cancer Stem Cell Enrichment.

Cancer research communications·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.2K

Prostate Cancer Progression Modeling Provides Insight into Dynamic Molecular Changes Associated with Progressive

Runpu Chen1, Li Tang2, Thomas Melendy1

  • 1Department of Microbiology and Immunology, University at Buffalo, State University of New York, Buffalo, New York.

Cancer Research Communications
|September 30, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel computational model for prostate cancer progression, integrating genomic and transcriptomic data from over 1,000 samples. The model offers a comprehensive view of tumor evolution, aiding in personalized treatment strategies.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models
08:43

Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models

Published on: September 18, 2018

20.1K

Related Experiment Videos

Last Updated: Jun 11, 2025

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.2K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models
08:43

Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models

Published on: September 18, 2018

20.1K

Area of Science:

  • Oncology
  • Computational Biology
  • Genomics

Background:

  • Prostate cancer is a leading global health concern for men.
  • Understanding tumor evolution is key for better diagnosis and treatment.
  • Existing methods for analyzing cancer evolution have limitations.

Purpose of the Study:

  • To develop a comprehensive prostate cancer progression model.
  • To integrate multi-dimensional genomic and transcriptomic data.
  • To identify key pathways and signatures in prostate cancer progression.

Main Methods:

  • Utilized a novel computational approach for model derivation.
  • Analyzed multidimensional data from The Cancer Genome Atlas (TCGA) study (497 tumor, 52 normal samples).
  • Validated the model using an independent cohort of 545 primary tumor samples.

Main Results:

  • Developed and validated a prostate cancer progression model using >1,000 samples.
  • Integrated transcriptomic and genomic data for a comprehensive view of tumor evolution.
  • Identified crucial signaling pathways, genetic events, and distinct transcription signatures associated with disease progression.

Conclusions:

  • The novel model provides a comprehensive understanding of prostate tumor progression.
  • Findings have significant implications for cancer research and personalized treatment strategies.
  • The model holds promise for guiding future therapeutic interventions in prostate cancer.